Atherosclerosis
Volume 193, Issue 2 , Pages 380-388 , August 2007

Prospective epidemiologic evidence of a “protective” effect of smoking on metabolic syndrome and diabetes among Turkish women—Without associated overall health benefit

  • Altan Onat

      Affiliations

    • Turkish Society of Cardiology, Nisbetiye cad. 37/24, Etiler 34335, Istanbul, Turkey
    • Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 212 351 6217; fax: +90 212 351 4235.
    • ,
  • Hakan Özhan

      Affiliations

    • Cardiology Department of I. Baysal U. Düzce, Istanbul, Turkey
    • ,
  • A. Metin Esen

      Affiliations

    • Kosuyolu Heart Hospital, Istanbul, Turkey
    • ,
  • Sinan Albayrak

      Affiliations

    • Cardiology Department of I. Baysal U. Düzce, Istanbul, Turkey
    • ,
  • Ahmet Karabulut

      Affiliations

    • S. Ersek Cardiovascular Surgery Center, Istanbul, Turkey
    • ,
  • Günay Can

      Affiliations

    • Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
    • ,
  • Gülay Hergenç

      Affiliations

    • S. Ersek Cardiovascular Surgery Center, Istanbul, Turkey
    • Biology Department, Yildiz Technical University, Istanbul, Turkey

Received 1 March 2006 ,Revised 19 June 2006 ,Accepted 6 July 2006.

References 

  1. Attvall S, Fowelin J, Lager I, von Schenck H, Smith U. Smoking induces insulin resistance: a potential link with the insulin resistance syndrome. J Intern Med. 1993;233:327–332
  2. Eliasson B, Atvall S, Taskinen MR, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb. 1994;14:1946–1950
  3. Rönnemaa T, Rönnemaa EM, Puukka P, Pyörala K, Laakso M. Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care. 1996;19:1229–1232
  4. U.S Department of Health and Human Services: Women and Smoking. A Report of the Surgeon General. Washington, DC: Department of Health and Human Services; 2001;
  5. Lee W-Y, Jung C-H, Park J-S, Rhee E-J, Kim S-W. Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diabet Res Clin Pract. 2005;67:70–77
  6. Weitzman M, Cook S, Auinger P, et al. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation. 2005;112:862–869
  7. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. Br Med J. 1995;310:555–559
  8. Foy CG, Bell RA, Farmer DF, Goff DC, Wagenknecht LE. Smoking and incidence of diabetes among U.S. adults: Findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2005;28:2501–2507
  9. Zhu S, St-Onge M-P, Heshka S, Heymsfield SB. Lifestyle behaviors associated with lower risk of having metabolic syndrome. Metabolism. 2004;53:1503–1511
  10. Shaten BJ, Smith GD, Kuller LH, Neaton JD. Risk factors for the development of type II diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:1331–1339
  11. Geslain-Biquez C, Vol S, Tichet J, Caradec A, D’Hour A, Balkau B D.E.S.I.R. Study Group. The metabolic syndrome in smokers. The D.E.S.I.R Study. Diabetes Metab. 2003;29:229–234
  12. Beziaud F, Halimi JM, Lecomte P, Vol S, Tichet J. Cigarette smoking and diabetes mellitus. Diabetes Metab. 2004;30:161–166
  13. Imamura H, Miyamoto N, Uchida K, Teshima K, Masuda Y, Kobata D. Cigarette smoking, BP, and serum lipids and lipoproteins in middle-aged women. J Physiol Anthropol Appl Human Sci. 2001;20:1–6
  14. Onat A, Sansoy V, Uysal Ö. Waist circumference and waist-to-hip ratio in Turkish adults: interrelation with other risk factors and association with cardiovascular disease. Int J Cardiol. 1999;70:43–50
  15. Erem C, Arslan C, Hacıhasanoglu A, et al. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon city, Turkey). Obes Res. 2004;12:1117–1127
  16. Satman I, Yilmaz MT, Şengül A, et al. and the TURDEP Group, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care. 2002;25:1551–1556
  17. Onat A, Hergenç G, Türkmen S, Yazıcı M, Sarı İ, Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism. 2006;55:445–452
  18. Onat A, Ceyhan K, Başar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels – a prospective and cross-sectional evaluation. Atherosclerosis. 2002;165:285–292
  19. Mahley RW, Palaoğlu E, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res. 1995;36:839–859
  20. Onat A, Avcı GŞ , Şenocak M, Örnek E, Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J Epidem Commun Health. 1992;46:470–476
  21. Keleş İ, Onat A, Toprak S, Avcı GŞ , Sansoy V. Family income a strong predictor of coronary heart disease events but not of overall deaths among Turkish adults: a 12-year prospective study. Prev Med. 2003;37:171–176
  22. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002;106:3143–3421
  23. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2006 May 7; [Epub ahead of print].
  24. Genuth S, Alberti KG, Bennett P, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Follow-up report on the diagnosis of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26:3160–3167
  25. Wyszynski DF, Waterworth DM, Barter PJ, et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005;95:194–198
  26. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd ed.. Geneva: WHO; 1982;pp. 124–127
  27. D’Agostino RB, Hamman RF, Karter AJ, Mykkänen L, Wagenknecht LE, Haffner SM. Insulin Resistance Atherosclerosis Study Investigators. Cardiovascular disease risk factors predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27:2234–2240
  28. Niskanen L, Laaksonen DE, Nyyssonen K, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension. 2004;44:859–865
  29. Carnethon MR, Fortmann SP, Palaniappan L, Duncan BB, Schmidt MI, Chambless LE. Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987–1998. Am J Epidemiol. 2003;158:1058–1067
  30. Ishizaka N, Ishizaka Y, Toda E-I, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005;25:1038–1044
  31. Oh SW, Yoon YS, Lee ES, et al. Association between cigarette smoking and metabolic syndrome: the Korea National Health and Nutrition Examination Survey. Diabetes Care. 2005;28:2064–2066
  32. Ostgren CJ, Lindblad U, Ranstam J, Melander A, Ranstam L. Skaraborg Hypertension and Diabetes Project, Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg Hypertension and Diabetes Project. Diabet Med. 2000;17:445–450
  33. Nakanishi N, Shiraishi T, Wada M. C-reactive concentration is more strongly related to metabolic syndrome in women than in men: the Minoh Study. Circ J. 2005;69:386–391
  34. Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism. 2005;54:902–909
  35. Ferrara CM, Kumar M, Nicklas B, McCrone S, Goldberg AP. Weight gain and adipose tissue metabolism after smoking cessation in women. Int J Obes. 2001;25:1322–1326

PII: S0021-9150(06)00399-6

doi: 10.1016/j.atherosclerosis.2006.07.002

Atherosclerosis
Volume 193, Issue 2 , Pages 380-388 , August 2007

Article Tools